GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases (GRABM-B)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01480583 |
|
Recruitment Status :
Completed
First Posted : November 29, 2011
Last Update Posted : July 13, 2016
|
Sponsor:
Angiochem Inc
Information provided by (Responsible Party):
Angiochem Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 2015 |
| Actual Study Completion Date : | October 2015 |
| Certification/Extension First Submitted : | July 11, 2016 |